Molecular Mechanisms and New Treatment Paradigm for Atrial Fibrillation

BACKGROUND: Atrial fibrillation (AF) represents the most common arrhythmia leading to increased morbidity and mortality, yet, current treatment strategies have proven inadequate. Conventional treatment with antiarrhythmic drugs carries a high risk for proarrhythmias. The soluble epoxide hydrolase en...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Circ Arrhythm Electrophysiol
Auteurs principaux: Sirish, Padmini, Li, Ning, Timofeyev, Valeriy, Zhang, Xiao-Dong, Wang, Lianguo, Yang, Jun, Lee, Kin Sing S., Bettaieb, Ahmed, Ma, Sin Mei, Lee, Jeong Han, Su, Demetria, Lau, Victor C., Myers, Richard E., Lieu, Deborah K., López, Javier E., Young, J. Nilas, Yamoah, Ebenezer N., Haj, Fawaz, Ripplinger, Crystal M., Hammock, Bruce D., Chiamvimonvat, Nipavan
Format: Artigo
Langue:Inglês
Publié: 2016
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4869994/
https://ncbi.nlm.nih.gov/pubmed/27162031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCEP.115.003721
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires